Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With Previous Formulae
NCT ID: NCT03013062
Last Updated: 2017-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2017-01-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ambulatory Blood Pressure and Prognosis
NCT00005363
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865
Effect of Blood Pressure on Myocardial Work in Patients With Hypertension
NCT05062811
Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice
NCT03607812
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
NCT00295542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WITH PULMONARY HYPERTENSION
It is defined as MPAP \> 25 mm Hg at rest or \>30 mm Hg during exercise with PVR \> 3 wood units and PCWP \< 15 mm Hg.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ganesh Kumar Munirathinam
Fellow resident, Department of anesthesia and intensive care, Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GANESH KUMAR M
Role: PRINCIPAL_INVESTIGATOR
PGIMER, CHANDIGARH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PGIMER
Chandigarh, , India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INT/IEC/2016/2641
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.